Table 2.
Relationship between Ebp1 expression and clinicopathological features of ACC patients
| Variables | N (%) | - | + | ++ | +++ | p-value | ||
|---|---|---|---|---|---|---|---|---|
| Age at diagnosis |
<=50 |
27 |
1(3.70%) |
6(22.22%) |
8(29.63%) |
12(44.44%) |
0.1597 |
|
| >50 |
39 |
9(23.08%) |
3(7.69%) |
16(41.03%) |
11(28.21%) |
|
||
| Gender |
Male |
33 |
4(12.12%) |
5(15.15%) |
12(36.36%) |
12(36.36%) |
0.6956 |
|
| Female |
33 |
6(18.18%) |
4(12.12%) |
12(36.36%) |
11(33.33%) |
0.6956 |
||
| Histologic subtypes |
Tubular |
38 |
3(7.89%) |
1(2.63%) |
15(39.47%) |
19(50.00%) |
0.0005 |
TvsS<.0001 |
| solid |
21 |
5(23.81%) |
6(28.57%) |
9(42.86%) |
1(4.76%) |
TvsC0.2075 |
||
| cribriform |
7 |
2(28.57%) |
2(28.57%) |
0(0.00%) |
3(42.86%) |
SvsC0.6393 |
||
| Lung metastasis |
+ |
16 |
8(50.00%) |
5(31.25%) |
2(12.50%) |
1(6.25%) |
<0.0001 |
|
| - |
50 |
3(6.00%) |
18(36.00%) |
12(24.00%) |
17(34.00%) |
|||
| Lymphatic metastasis |
+ |
14 |
8(57.14%) |
6(42.86%) |
0(0.00%) |
0(0.00%) |
<0.0001 |
|
| - |
52 |
3(5.77%) |
17(32.69%) |
14(26.92%) |
18(34.62%) |
|||
| Perineural invasion |
+ |
23 |
9(39.13%) |
8(34.78%) |
4(17.39%) |
2(8.70%) |
0.002 |
|
| |
- |
43 |
2(4.65%) |
15(34.88%) |
10(23.26%) |
16(37.21%) |
|
|
| TNMstaging |
T1-2 |
42 |
3(7.14%) |
6(14.29%) |
15(35.71%) |
18(42.86%) |
0.0235 |
|
| T3-4 | 24 | 7(29.17%) | 3(12.50%) | 9(37.50%) | 5(20.83%) | |||